HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice

MLA

Egbert Hoiczyk, et al. “HPV16 L1 Capsid Protein Expressed from Viable Adenovirus Recombinants Elicits Neutralizing Antibody in Mice.” Vaccine, vol. 25, no. 17, Mar. 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....269d9782be9d158e11c90cb5529d024a&authtype=sso&custid=ns315887.

APA

Egbert Hoiczyk, Mark C. Siracusa, Gary Ketner, Michael Berg, Richard B.S. Roden, & Ratish Gambhira. (2006). HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice. Vaccine, 25(17).

Chicago

Egbert Hoiczyk, Mark C. Siracusa, Gary Ketner, Michael Berg, Richard B.S. Roden, and Ratish Gambhira. 2006. “HPV16 L1 Capsid Protein Expressed from Viable Adenovirus Recombinants Elicits Neutralizing Antibody in Mice.” Vaccine 25 (17). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....269d9782be9d158e11c90cb5529d024a&authtype=sso&custid=ns315887.